KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients-Reference-Cited by-同舟云学术

KCNQ1 gene polymorphisms are associated with the therapeutic efficacy of repaglinide in Chinese Type 2 diabetic patients

Published:2012-04-23 Issue:5 Volume:39 Page:462-468
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Dai Xing-Ping¹,Huang Qiong²,Yin Ji-Ye¹,Guo Yu¹,Gong Zhi-Cheng¹,Lei Min-Xiang³,Jiang Tie-Jian³,Zhou Hong-Hao¹,Liu Zhao-Qian¹

Affiliation:

1. Hunan Key Laboratory of Pharmacogenetics; Institute of Clinical Pharmacology, Central South University; Changsha; China

2. Key Laboratory of Anti-inflammatory and Immunopharmacology of Education Ministry of China; Institute of Clinical Pharmacology, Anhui Medical University; Hefei; China

3. Department of Endocrinology; Xiang-Ya Hospital of Central South University; Changsha; China

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1681.2012.05701.x/fullpdf

Reference25 articles.

1. Type 2 diabetes: Principles of pathogenesis and therapy;Stumvoll;Lancet,2005

2. SNPs in KCNQ1 are associated with susceptibility to Type 2 diabetes in East Asian and European populations;Unoki;Nat. Genet.,2008

3. Variants in KCNQ1 are associated with susceptibility to Type 2 diabetes mellitus;Yasuda;Nat. Genet.,2008

4. Candidate gene association study in Type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action;Barroso;PLoS Biol.,2003

5. K(IR)6.2 polymorphism predisposes to Type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels;Schwanstecher;Diabetes,2002

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KCNQ1 rs2237895 gene polymorphism increases susceptibility to type 2 diabetes mellitus in Asian populations;World Journal of Diabetes;2024-03-15

2. Pharmacogenomics: The roles of genetic factors on treatment response and outcomes in diabetes;Internet of Things and Machine Learning for Type I and Type II Diabetes;2024

3. Pharmacogenomics and diabetes;Pharmacogenomics;2023

4. Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses;Frontiers in Cardiovascular Medicine;2022-02-17

5. Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice;Pharmacogenomics and Personalized Medicine;2021-11